Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Radiation Oncology, Biology, Physics|June 18, 2018
Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer CentreAndrew Bang, Wayne S Kendal, Scott A Laurie, et al.
Clinical and Translational Radiation Oncology|March 30, 2019
Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)Rima S Pathak, Jason R Pantarotto, Graham Cook, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
The role of radiation treatment in pleural mesothelioma: Highlights of the 14th International Conference of the International mesothelioma interest groupRobert M MacRae, Miranda Ashton, Olivia Lauk, et al.
Radiology|September 29, 2006
Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsyPrachi P Agarwal, Jean M Seely, Fred R Matzinger, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Cancer Clinic Redesign: Opportunities for Resource OptimizationMichael Fung-Kee-Fung, Rachel S Ozer, Bill Davies, et al.
JAMA Oncology|November 26, 2015
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical TrialBenjamin Movsas, Chen Hu, Jeffrey Sloan, et al.
JAMA Oncology|June 27, 2024
Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical TrialStephen G Chun, Chen Hu, Ritsuko U Komaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical TrialStephen G Chun, Chen Hu, Hak Choy, et al.
Cancer Research Communications|September 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLCJoanne B Weidhaas, Chen Hu, Ritsuko Komaki, et al.
Journal of the National Cancer Institute|January 19, 2018
Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)Ting-Yuan David Cheng, Amy K Darke, Mary W Redman, et al.
Pageof 1